Aurinia Pharmaceuticals
AUPH
AUPH
184 hedge funds and large institutions have $548M invested in Aurinia Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 68 increasing their positions, 45 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 190 → 184 (-6)
10% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 30
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
184
Holding in Top 10
–
Calls
$30.4M
Puts
$21.7M
Top Buyers
| 1 | +$9.34M | |
| 2 | +$5.69M | |
| 3 | +$4.37M | |
| 4 |
Morgan Stanley
New York
|
+$4.23M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.12M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$9.07M | |
| 3 | -$5.57M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3.35M |
| 5 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
-$3.01M |